<DOC>
	<DOC>NCT01813630</DOC>
	<brief_summary>A study demonstrates the non-inferiority of DA-3002 when compared with Genotropin®.</brief_summary>
	<brief_title>A Clinical Study to Assess the Efficacy and Safety of DA-3002</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<criteria>Diagnosed with Turner's Syndrome through chromosome analysis The chronological age: 2≤AGE≤12 The yearly growth rate should be less than 6cm; the bone age should be equal or less than 12; the height ≤ 10th percentile for the heights of their agemates Before the adolescence, Tuner stage I (breast) Normal thyroid function Growth hormone was administered for 12 months or longer in the past Treated with estrogen or adrenal androgens for 12 months or longer in the past Malignancy, CNS Trauma, Psychiatric Disorder</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Turner's Syndrome</keyword>
	<keyword>Short Stature</keyword>
	<keyword>Dwarfism</keyword>
</DOC>